New avenues in the treatment of ischemic heart disease - Stem cell therapy
Faced with the large number of patients with ischemic heart disease and high mortality rates, traditional drug treatments come with the risks of drug resistance and rebound effects after discontinuation, as well as the shortcomings of surgical treatments such as poor blood circulation and the inability to restore necrotic myocardium. This article starts from the perspective of stem cell regenerative medicine, focusing on the stem cell therapy for ischemic heart disease, and provides a comprehensive review of the types of stem cells and transplantation methods. It also includes further summaries and prospects, believing that more comprehensive and improved treatment methods will emerge in the future to benefit patients.
Authors
- Xiaolong Guo (ORCID: https://orcid.org/0009-0007-1192-6203)
- Wenhui Li (ORCID: https://orcid.org/0000-0003-1305-7404)
- Xi Chen (ORCID: https://orcid.org/0009-0006-4574-6166)
- Jing Gou
- Xuewu Zhang
Institutions
- Zunyi Medical University (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Theoretical and Natural Science
- Published
- 2024-10-12
- DOI
- https://doi.org/10.54254/2753-8818/54/2024au0116
- Primary Topic
- Pluripotent Stem Cells Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00